Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
t3TsZExCBzAhVBgX
